Work

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

Year: 2019

Type: article

Study design: Clinical Trial

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.04.017

Authors: Armin Ghobadi, Mark A. Fiala, Michael Rettig, Mark Schroeder, Geoffrey L. Uy, Keith Stockerl-Goldstein, Peter Westervelt, Ravi Vij, John F. DiPersio

Institution: Washington University in St. Louis

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, Washington University School of Medicine in St. Louis, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: BM NICHE DISRUPTION AND IMMUNOTHERAPY IN HEMATOLOGICAL MALIGNANCIES, Washington University Institute of Clinical and Translational Sciences (KL2)

OpenAlex ID: W2942967291

FWCI: 0.53

Cites: 13

Cited by: 9

Related to: 10